30 closest matches · ranked by relevance
Child, Hospitalized
Primary: Child Self-reported Pain: Wong-Baker Faces Pain Rating Scale — 2; 2; 2 score on a scale — p=0.511
Pain
Primary: Pain Scale on Numeric Rating Scale (NRS) ( 0 to 10) — 1.7; 4.7 units on a scale
Pain
Primary: Pain Difference Caused by PIVC (Peripheral Intravenous Catheter) Rated by NRS (Numeric Rating Scale) Between Application of 10% Licocaine Spray and Placebo-for the…
Pain · Phlebotomy · Palliative Care
Primary: Percentage of Patients With No or Minor Pain (VAS<3) — 38.0; 21.3 percentage of participants
Central Line Catheters
Primary: Adherence to Clinical Guidelines for Catheter Interventions and Management — 12; 0; 0; 11 # of catheter-related incidents
IV Access
Primary: Number of Participants With Successful Cannulation of the Internal Jugular Vein — 34 Participants
IV Catheter-Related Infection or Complication · Vascular Access Complication · Peripheral Venous Access
Primary: Blood Sampling Functionality — 70.19; 112.9 hours
Indication for Peripheral Intravenous Catheterisation
Primary: Patent Indwell Time Between PIVCs of Different Length and Gauge. — 40.19; 42.96; 35.91; 36.91 hours
End Stage Renal Disease
Primary: Percentage of Successful Hemodialysis Sessions — 100; 98.9 percentage of successful sessions — p=.008
Adult Patients With Peripherally Inserted Central Catheters
Primary: Rate of PICC Line Occlusions — 37 percentage of enrolled subjects
Intravenous Access
Primary: First Attempt Success Rate — 17; 11 Participants
Obesity · Vascular Diseases
Primary: Successful First Attempt Peripheral Venous Cannulation — 96 participants
Transmission, Blood, Recipient/Donor
Primary: Plasma Supernatant Hemoglobin — 26.8; 28.0 mg/dL
Liver Neoplasms · Hepatectomy
Primary: Total Intraoperative Blood Loss, by Measurement of Change in Hemoglobin Levels — 862; 872; 761; 872 mL
Catheter Infection · Catheter Thrombosis · Catheter Complications
Primary: Upper Extremity CR-UEVT — 7; 11 Participants
Procedural Complication
Primary: First Attempt Success Rates With the AccuVein 300 Device Versus Standard Method — 92; 92 Participants
Critical Illness
Primary: Central Line Placement Success — 82; 108 participants — p=<0.001
Venous Leg Ulcer
Primary: Change From Baseline in Wound Perimeter — 29.36; 43.64 mm
End Stage Renal Disease · AV Fistula · Kidney Failure
Primary: Use of Venous Window Needle Guide to Obtain Arteriovenous Access for Hemodialysis — 49 participants
Blood Loss
Primary: Detect by Non-invasive Monitoring a Change in Blood Volume During a Whole Blood Draw — 0; 45 participants
PICC · Central Venous Catheter · Central Line
Primary: Participants With Complications With Central Access Including Insertion — 14; 10 Participants — p=0.271
Healthy · Disease, Chronic · Acute Disease
Primary: Chemistry Analytes [Albumin (ALB) and Total Protein (TP)] in Serum Measured Using the Silica Clot Activator for Serum Samples — 3.746; 3.787; 6.77; 6.83 g/dL
Saphenous Vein Cannulation
Primary: Percentage of Participants With First Attempt Success of Saphenous Vein Cannulation — 51.0; 90.2 percent of participants
End Stage Renal Disease · AV Fistula · Fistula
Primary: Maturation Success Rate at 90 Days — 92 Participants
Arteriovenous Fistula · Hemodialysis · Dialysis Adequacy
Primary: Number of Fistula Needle Direction — 72; 92 Participants
Vascular Access
Primary: Number of Participants With Success in the First Attempt — 56; 71; 53 Participants
Percutaneous Closure of Arteriotomy in Common Femoral Artery
Primary: Major Vascular Complications Directly Related to Device — 0 percentage of participants
Healthy
Primary: Assess the Sample Integrity of Tasso+™ — 23.1; 75.8; 40.5 percentage of samples
Tourniquet
Primary: Peripheral IV Access Success Rate — 42; 43 Participants — p=0.95
Cardiac Diagnostic Procedure · Cardiac Interventional Procedure · Femoral Access Site Closure
Primary: Assessment of Venous Thrombosis — 0; 0 Participants